Analysis of Clinical Subphenotypes in Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the MRSA-GEIRAS-SEIMC Study - Takeaways - MDSpire

Analysis of Clinical Subphenotypes in Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the MRSA-GEIRAS-SEIMC Study

  • By

  • Sofía De La Villa

  • Nuria Fernández-Hidalgo

  • Francesc Escrihuela-Vidal

  • Rosa Escudero-Sánchez

  • Itxasne Cabezón

  • Lucía Boix-Palop

  • Beatriz Díaz-Pollán

  • Ane Josune Goikoetxea

  • María José García-País

  • Lucía Ramos-Merino

  • María Teresa Pérez-Rodríguez

  • Ángela Crespo

  • Lara del Río

  • José María Bellón-Cano

  • Patricia Muñoz

  • on behalf of

  • MRSA-GEIRAS-SEIMC study group

  • Damaris Berbel

  • Luis Buzón-Martín

  • David Campany

  • Alex García-Tellado

  • Inmaculada Grau

  • José Manuel Guerra-Laso

  • Joan Roig-Sanchis

  • Celia Sánchez-Martínez

  • Oscar Sanz

  • Fiorana Silvante

  • Belén Viñado

  • Luciana Urbina

  • Ana V Halperin

  • Mariona Xercavins

  • December 16, 2025

  • 0 min

Share

  • 1

    The study identified four clinical subphenotypes of methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) based on various clinical factors.

  • 2

    Subphenotype S2, characterized by older age and high comorbidity, had the highest 90-day mortality rate at 47.4%.

  • 3

    Cox regression analysis revealed significantly increased mortality risk for subphenotypes S2 and S4 compared to S1.

  • 4

    The study included 419 MRSAB patients from 15 Spanish hospitals, emphasizing the need for tailored treatment approaches.

  • 5

    Further research is required to integrate identified subphenotypes into clinical practice for better patient management.

Original Source(s)

Related Content